Interparfums is under fresh scrutiny as analysts reaffirm a modeled fair value of US$111.20 per share, keeping the price target level while refining the underlying inputs. Supporters point to the ...

Gilead will pay $1.675 billion upfront plus up to $500 million in milestones to obtain OM336, positioning BCMA-targeted ...

Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully improved financial terms ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today it has entered into a definitive agreement to acquire Ouro Medicines, a ...

Germany and France had pledged to work together on the FCAS sixth-generation fighter jet, but their different priorities for ...

A ranking Philippine Navy (PN) official on Monday said plans are afoot to expand the "Insider Threat Program" (ITP) to other ...

As I was preparing to write this column, I looked up the word "fail." To my surprise, the web version of Oxford Dictionary has a top 1,000-word feature. The word "fail" is firmly nested in its list of ...

DEAR DR. ROACH: What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low blood platelet count, I ...

The acquisition is expected to close during the first half of 2026 Aero Norway is based in Stavanger, Norway ITP Aero is an aerospace propulsion company ITP Aero, which is owned by Bain Capital, has ...

Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...

Current second-line treatments for immune thrombocytopenia (ITP) require long-term administration. Ianalumab, a monoclonal antibody targeting B cells, is being assessed as a short-course second-line ...